Luis Valente , CEO of ILOF, discusses the challenges and opportunities in scaling personalized healthcare. ILOF is a deep tech health tech company that collects and processes large amounts of data to identify the right patients for clinical studies. The goal is to bring personalized medicine to the masses by selecting the most effective treatments for individual patients. Valente shares insights on starting a deep tech startup, the importance of creating goodwill, and the differences between the US and European markets. He also discusses the limitations of their solution and the future of personalized medicine.
Chapters
00:00Introduction and Background
01:02Falling in Love with the Problem
03:14Starting a Deep Tech Startup
04:33Considerations for Building a Company in the US
07:26Creating Goodwill and Building a Team
10:11Challenges in the Early Stages
12:01Recognition and Achievements
13:47The Process and Impact of ILOF’s Solution
15:35The Future of Personalized Medicine
20:35US Market vs. European Market
24:10Raising Capital in the US
26:17Building a Company in the US: When and Why
27:07Conclusion
